Ufp Technologies (UFPT) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.40% |
| Dec 31, 2025 | 19.10% |
| Sep 30, 2025 | 18.56% |
| Jun 30, 2025 | 17.90% |
| Mar 31, 2025 | 16.75% |
| Dec 31, 2024 | 16.17% |
| Sep 30, 2024 | 16.12% |
| Jun 30, 2024 | 15.69% |
| Mar 31, 2024 | 15.34% |
| Dec 31, 2023 | 15.29% |
| Sep 30, 2023 | 14.94% |
| Jun 30, 2023 | 14.70% |
| Mar 31, 2023 | 14.36% |
| Dec 31, 2022 | 13.94% |
| Sep 30, 2022 | 13.34% |
| Jun 30, 2022 | 11.80% |
| Mar 31, 2022 | 11.52% |
| Dec 31, 2021 | 11.46% |
| Sep 30, 2021 | 11.34% |
| Jun 30, 2021 | 11.42% |
| Mar 31, 2021 | 11.53% |
| Dec 31, 2020 | 11.30% |
| Sep 30, 2020 | 11.17% |
| Jun 30, 2020 | 11.11% |
| Mar 31, 2020 | 11.36% |
| Dec 31, 2019 | 11.27% |
| Sep 30, 2019 | 10.88% |
| Jun 30, 2019 | 10.53% |
| Mar 31, 2019 | 10.46% |
| Dec 31, 2018 | 10.41% |
| Sep 30, 2018 | 10.73% |
| Jun 30, 2018 | 10.82% |
| Mar 31, 2018 | 10.91% |
| Dec 31, 2017 | 11.05% |
| Sep 30, 2017 | 11.75% |
| Jun 30, 2017 | 12.31% |
| Mar 31, 2017 | 12.82% |
| Dec 31, 2016 | 12.77% |
| Sep 30, 2016 | 13.79% |
| Jun 30, 2016 | 14.54% |
| Dec 31, 2015 | 15.57% |